Medacta USA, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$47Mgeneral payments (2019-2025)
$3.9Mresearch payments (2019-2025)
3,161clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Gmk Sphere $6.0M associated (2023-2025)
- Primary Shoulder $1.7M associated (2023-2025)
- Amistem $1.5M associated (2023-2025)
- Quadra $976K associated (2023-2025)
- Myknee $881K associated (2023-2025)
- Must $678K associated (2023-2025)
- Myspine $607K associated (2023-2025)
- Mpact $476K associated (2023-2025)
- Ka Instruments $305K associated (2023-2025)
- Mecta $300K associated (2023-2025)
- Moto Uni $292K associated (2023-2025)
- Spherika $205K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Stephen Howell | Sacramento, CA | Orthopaedic Surgery | $8,240,324.26 |
| Tyler Goldberg | Austin, TX | Adult Reconstructive Orthopaedic Surgery | $4,568,783.56 |
| Robert Greenhow | Lone Tree, CO | Orthopaedic Surgery | $2,812,206.51 |
| David Loucks | Lone Tree, CO | Orthopaedic Surgery | $2,720,474.24 |
| Matthew Saltzman | Seattle, WA | Orthopaedic Surgery | $1,598,593.51 |
| Jeffrey Kerina | Leesburg, FL | Orthopaedic Surgery | $1,039,882.20 |
| Akbar Nawab | Louisville, KY | Orthopaedic Surgery | $1,004,165.26 |
| Anup Shah | Phoenix, AZ | Sports Medicine (Orthopaedic Surgery) | $960,326.63 |
| Ryan Molli | Meadville, PA | Orthopaedic Surgery | $828,684.84 |
| John Masonis | Charlotte, NC | Orthopaedic Surgery | $772,991.57 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.